Name
DAPTOMYCIN
Mode of Action
DAPTOMYCIN IS A LIPOPEPTIDE ANTIBACTERIAL THAT IS REPORTED TO HAVE A SPECTRUM OF ANTIBACTERIAL ACTIVITY SIMILAR TO THAT OF VANCOMYCIN AND GREATER POTENCY AGAINST MANY BACTERIAL STRAINS IN VITRO. IT IS REPORTED TO SHOW ANTIMICROBIAL SYNERGY IN VITRO WITH THE AMINOGLYCOSIDES AGAINST ENTEROCOCCI AND STAPHYLOCOCCUS AUREUS.
Dosage
BY INTRAVENOUS INFUSION OVER 30 MTS PERIOD OR IV OVER 2 MTS, ADULT OVER 18 YEARS, 4 MG/KG ONCE DAILY FOR 7 - 14 DAYS STAPHYLOCOCCUS AUREUS BACTERAEMIA OR RT SIDED ENDOCARITIS: 6 MG /KG DAILY IV FOR 2-6 WKS DEPENDING ON DIAGNOSIS.
Drug Group
[LIPOPEPTIDE ANTIBACTERIAL]
Cross Reaction
NONE REPORTED
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph